SHANDONG KEXING BIOPRODUCTS CO., LTD

Zhangqiu,  Jinan 
China
http://www.sdkexing.com
  • Booth: 2427

Founded in 1997, Shandong Kexing Bioproducts integrates R&D, manufacture, and sales of biopharmaceuticals. Genzon Group and Shenzhen Kexing Biotech are its major stock holders. The company develops recombinant gene drugs and micro-ecological drugs, to serve the clinical treatment needs of kidney diseases, tumor, and gastrointestinal diseases. It has become a leading player in China's biopharmaceutical industry. The main products are as follows: 1. Recombinant human erythropoietin injection (rh-EPO), 2.Recombinant human granulocyte colony-stimulating factor injection (G-CSF/ Filgrastim), 3.Combined clostridium butyricum and bifidobacterium preparation, live